Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have already received results from a genetic test for BRCA1 or BRCA2 gene changes.
- People who have had an internal pelvic ultrasound scan that includes at least one clear image of a healthy ovary.
- People whose ultrasound images are saved in a specific standard digital file format called DICOM.
Who may not be able to join:
- People who have personally been diagnosed with ovarian cancer.
- People whose pelvic ultrasound showed abnormal findings on the ovaries — such as certain types of cysts or tumours — unless the only finding was a simple functional cyst (confirm with trial site).
- People whose BRCA1 or BRCA2 genetic test results did not come from a laboratory certified to a standard called ISO 15189 (confirm with trial site).
- People who are not willing to provide written consent to participate.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Camilla Nero, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phone: +390630156779
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Radiogenomics model for predicting germline breast cancer.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.